Photo taken from Oncogene Cancer Research/X
Jul 27, 2024, 23:04
LUNGevity Foundation and Oncogene Cancer Research are joining up with 23andMe to advance lung cancer research
Amy C. Moore, VP, Global Engagement and Research Partnerships at LUNGevity Foundation, shared a post by Oncogene Cancer Research, on X:
“LUNGevity Foundation is is also part of this study led by 23andMe to learn more about the genetics of lung cancer and how that may inform early detection, treatment and more.”
Quoting Oncogene Cancer Research‘s post:
“We’re joining up with 20+ advocacy organisations and 23andMe to advance lung cancer research. Open to people 18+ diagnosed with lung cancer and living in the US. Learn more about how your genetics could help fuel treatment discoveries and enrol in our study.”
Read further.
Source: Amy C. Moore/X and Oncogene Cancer Research/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 11:30
Dec 21, 2024, 11:25
Dec 21, 2024, 11:18
Dec 21, 2024, 11:12
Dec 21, 2024, 11:06
Dec 21, 2024, 10:38